MiSight® 1 day Contact Lenses Now Available!
- Myopia management starts 1 day at a time
- A simple-to-wear, one-day soft contact lens thrown away at the end of each day
The cornerstone of our comprehensive Brilliant Futures™ Myopia Management approach, MiSight® 1 day is a daily wear, single use contact lens that has been clinically proven and FDA-approved* to slow the progression of myopia (nearsightedness) aged 8-12 years old at the start of treatment.
A closer look at your child's distance vision
What can you do when your child tells you they’re struggling to see the board at school? Or that things are beginning to look blurrier the further they get from them? One cause for this blurry distance vision could be myopia. Myopia, also known as nearsightedness, causes light rays to focus at a point in front of the retina rather than directly on the surface, owing to elongation of the eye.
Myopic progression is when prescriptions increase over time, and higher prescriptions have been linked to sight-threatening conditions later in life such as, retinal detachment, glaucoma and myopic maculopathy.1,2
Even children with fairly low prescriptions have a higher risk of glaucoma and retinal detachment compared to non-myopic children, and that risk multiplies as their prescriptions get stronger.3
81% of eye care professionals agree that myopia is one of the biggest problems impacting children’s eyesight today.4 But until now, traditional eyeglasses and contact lenses available have only been developed to correct blurred distance vision, but they do nothing to help slow gradual prescription increases.
81% of eyecare professionals agree myopia is one of the biggest problems impacting children's eyesight today.4
Focusing on your child's vision, now and in the future
Generally, myopia first occurs in school-age children and progresses until about age 20.5 According to the Centre for Ocular Research and Education at the University of Waterloo, almost 30% of children ages 11-13 are myopic.6 This is due in part to changing lifestyles, with children spending less time outdoors and more time focusing on close objects like digital screens.
With the U.S. Food and Drug Administration (FDA) approval of a new soft contact lens, MiSight® 1 day, CooperVision will empower Eye Care Professionals and Parents to take on pediatric myopia’s* growing prevalence and severity with a proven approach scientifically designed for the challenge.
MiSight® 1 day will be the cornerstone of a new comprehensive Brilliant Futures Myopia Management initiative offered by CooperVision that be available on November 1, 2020.
Click here to learn more about Myopia Management.
Canadian Indications for Use: MiSight (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.
* USA Indications for Use: MiSight® 1 Day (omafilcon A) Soft (Hydrophilic) Contact Lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
**Based on a clinical study in which participants were between the ages of 8 to 12 at initial fit.
1. Xu L, et al. High myopia and Glaucoma susceptibility for the Beijing Eye Study. Ophthalmology. 2007;114(2):216-20.
2. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622-660.
3. Bourne RR, et al. Causes of vision loss worldwide, 1990-2010: a systemic analysis. Lancet Glob Health. 2013;1(6):e339-49.
4. CooperVision data on file 2019. Myopia Awareness, The Harris Poll online survey 6/27/19 to 7/18/19 of n=313 ECPs (who see at least 1/month myopic child, age 8-15) in U.S.
5. Yu L, et al. Epidemiology, genetics and treatments for myopia. Int J Ophthalmol. 2011;4(6):658-69.
6. Yang, M., Luensmann, D., Fonn, D. et al. Myopia prevalence in Canadian school children: a pilot study. Eye 32, 1042–1047 (2018). https://doi.org/10.1038/s41433-018-0015-5